Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?

被引：77
|
作者：
Berasain, Carmen [1 ]
机构：
[1] Univ Navarra, CIMA, Div Hepatol & Gene Therapy, Pamplona 31008, Spain
来源：
GUT | 2013年 / 62卷 / 12期
关键词：
Drug Resistance; Gene Targeting; Hepatocellular Carcinoma; Liver; Molecular Carcinogenesis; CELLS;
D O I：
10.1136/gutjnl-2013-304564
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1674 / 1675
页数：2
相关论文
共 50 条
  • [21] Too Many versus Too Few Platelets in Patients with Hepatocellular Carcinoma: Good or Bad?
    Huo, Teh-Ia
    Liu, Po-Hong
    LIVER CANCER, 2020, 9 (01) : 108 - 109
  • [22] Sorafenib in Hepatocellular Carcinoma
    Bajetta, Emilio
    Procopio, Giuseppe
    Colombo, Andrea
    Guadalupi, Valentina
    Verzoni, Elena
    Pietrantonio, Filippo
    Pusceddu, Sara
    Manzoni, Mariangela
    Gevorgyan, Arpine
    Buzzoni, Roberto
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 277 - 287
  • [23] Sorafenib in hepatocellular carcinoma
    Josephs, Debra H.
    Ross, Paul J.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (08) : 451 - 456
  • [24] Sorafenib - In hepatocellular carcinoma
    Simpson, Dene
    Keating, Gillian M.
    DRUGS, 2008, 68 (02) : 251 - 258
  • [25] Mechanisms of doxorubicin resistance in hepatocellular carcinoma
    Cox, Josiah
    Weinman, Steven
    HEPATIC ONCOLOGY, 2016, 3 (01)
  • [26] Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
    Manfredi, Giulia Francesca
    Celsa, Ciro
    John, Chloe
    Jones, Charlotte
    Acuti, Nicole
    Scheiner, Bernhard
    Fulgenzi, Claudia Angela Maria
    Korolewicz, James
    Pinter, Matthias
    Gennari, Alessandra
    Mauri, Francesco A.
    Pirisi, Mario
    Minisini, Rosalba
    Vincenzi, Federica
    Burlone, Michela
    Rigamonti, Cristina
    Donadon, Matteo
    Cabibbo, Giuseppe
    D'Alessio, Antonio
    Pinato, David James
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1955 - 1971
  • [27] Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma
    Wei, Shuhua
    Wei, Fenghua
    Li, Mengyuan
    Yang, Yuhan
    Zhang, Jingwen
    Li, Chunxiao
    Wang, Junjie
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 163
  • [28] Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma
    Xiao, Hong
    Chen, Hangyu
    Zhang, Lei
    Duolikun, Maimaitiyasen
    Zhen, Baixin
    Kuerban, Subinuer
    Li, Xuehui
    Wang, Yuxi
    Chen, Long
    Lin, Jian
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [29] MiRNA Expression Profiling of Sorafenib Response and Resistance in Hepatocellular Carcinoma
    Yousef, George
    Butz, Henriett
    Kerbel, Robert
    Mozes, Roy
    Patocs, Attila
    Kerbel, Robert
    LABORATORY INVESTIGATION, 2015, 95 : 200A - 201A
  • [30] Galectin-1 modulates sorafenib resistance in hepatocellular carcinoma
    Tung, Hsu W.
    Su, Yen H.
    Chiu, Ching F.
    Chen, Hsin A.
    Shen, Shing C.
    CANCER SCIENCE, 2022, 113 : 1058 - 1058
12345